BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nippon Shinyaku readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Nippon Shinyaku's drugs run\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05179226-591@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT05179226)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3\, Iron De
 ficiency Anemia.\nStudy: Multi-center Trial of Ferric Derisomaltose in Chi
 ldren 0 to <18 Years of Age With Iron Deficiency Anemia\nEstimated primary
  completion: 30 April 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/ferric-derisomaltose#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT05179226
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05064878-8885@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20271108
DTEND;VALUE=DATE:20271109
SUMMARY:Fintepla (Fenfluramine): Phase 3 readout est. (NCT05064878)
DESCRIPTION:Fintepla (Fenfluramine)\, phase 3\, Epilepsy.\nStudy: A Phase 3
  Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 
 Deficiency Disorder.\nEstimated primary completion: 8 November 2027. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/fenfluramine#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT05064878
URL:https://assetmemo.bio/drug/fenfluramine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06929806-591@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20271201
DTEND;VALUE=DATE:20271202
SUMMARY:Monoferric / Monofer (Ferric derisomaltose): Phase 3 readout est. (
 NCT06929806)
DESCRIPTION:Monoferric / Monofer (Ferric derisomaltose)\, phase 3\, Heart F
 ailure.\nStudy: Multi-center Trial of Ferric Derisomaltose Versus no Intra
 venous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Fail
 ure\nEstimated primary completion: 1 December 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT06929806
URL:https://assetmemo.bio/drug/ferric-derisomaltose#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07236606-10822@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:Clemidsogene lanparvovec: Phase 3 readout est. (NCT07236606)
DESCRIPTION:Clemidsogene lanparvovec\, phase 3\, Mucopolysaccharidosis Type
  II.\nStudy: RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter
  Syndrome)\nEstimated primary completion: 30 April 2028. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/clemidsogene-lanparvovec#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT07236606
URL:https://assetmemo.bio/drug/clemidsogene-lanparvovec#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07503444-8885@assetmemo.bio
DTSTAMP:20261121T004959Z
DTSTART;VALUE=DATE:20290206
DTEND;VALUE=DATE:20290207
SUMMARY:Fintepla (Fenfluramine): Phase 3 readout est. (NCT07503444)
DESCRIPTION:Fintepla (Fenfluramine)\, phase 3\, Rett Syndrome.\nStudy: A Ph
 ase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome\nEstimated prim
 ary completion: 6 February 2029. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/fenfluramine#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07503444
URL:https://assetmemo.bio/drug/fenfluramine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
